Natpara

Generic name: Parathyroid Hormone
Drug class: Parathyroid hormone and analogs

Usage of Natpara

Natpara is a manmade form of a hormone that occurs naturally in the body.

Natpara is used together with calcium and vitamin D to treat hypocalcemia (low levels of calcium in the blood) in people who also have low levels of parathyroid hormone.

Natpara is usually given after calcium and vitamin D alone have been tried without success.

Natpara is available only under a special program. You must be registered in the program and understand the risks and benefits of this medicine.

Natpara side effects

Get emergency medical help if you have signs of an allergic reaction to Natpara: hives, itching; fast heartbeats, feeling light-headed, difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • new or unusual pain that is ongoing;
  • swelling or tender lumps under your skin;
  • a seizure; or
  • high calcium levels - nausea, vomiting, constipation, increased thirst or urination, muscle weakness, bone pain, confusion, lack of energy, or tired feeling.

    • After you stop using this medicine, you may have low calcium levels. Tell your doctor if you have numbness or tingling around your mouth or in your fingers and toes, muscle twitching in your face, cramps in your hands and feet, mood changes, or problems with thinking or memory.

    Common Natpara side effects may include:

  • tingling, burning, or prickly feeling in your skin;
  • headache;
  • nausea, vomiting, diarrhea; or
  • joint pain.

    • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Natpara

    You should not use Natpara if you are allergic to parathyroid hormone.

    In animal studies, parathyroid hormone caused bone cancer. However, it is not known whether these effects would occur in humans. Ask your doctor about your risk.

    To make sure Natpara is safe for you, tell your doctor if you have ever had:

  • high levels of calcium in your blood;
  • high levels of alkaline phosphatase in your blood;
  • bone cancer;
  • Paget's disease or other bone disorders; or
  • radiation treatment.

    • Tell your doctor if you are pregnant or plan to become pregnant. It is not known whether parathyroid hormone will harm an unborn baby.

    Having hypocalcemia during pregnancy may increase the risk of miscarriage, premature birth, hypocalcemia in the baby, or eclampsia (dangerously high blood pressure that can lead to medical problems in both mother and baby). The benefit of treating hypocalcemia with Natpara may outweigh any risks to the baby.

    You should not breastfeed while using this medicine. If you do breastfeed, tell your doctor if you notice symptoms in the nursing baby such as fussiness, weakness, stomach pain, poor feeding, vomiting, weight loss, constipation, more wet diapers than usual, muscle spasms, or tremors.

    Natpara is not approved for use by anyone younger than 18 years old, or by anyone whose bones are still growing.

    Relate drugs

    How to use Natpara

    Usual Adult Dose for Hypocalcemia:

    Prior to initiating therapy: -COnfirm 25-hydroxyvitamin D stores are sufficient; if not, correct insufficiency per standard of care -Confirm serum calcium is above 7.5 mg/dL INITIAL dose: 50 mcg suBCUTAneously once a day -For patients using active forms of vitamin D: Decrease active vitamin D dose by 50% if serum calcium is above 7.5 mg/dL -Maintain calcium supplement doses in those using calcium supplements -Measure serum calcium concentration within 3 to 7 days -Adjust active vitamin D dose or calcium supplement dose, or both based on serum calcium value and clinical assessment (see dosage adjustment section) ADJUST dose in increments of 25 mcg every 4 weeks if serum calcium cannot be maintained above 8 mg/dL without an active form of vitamin D and/or calcium supplementation MAINTENANCE dose: 25 to 100 mcg subcutaneously once a day Comments: -Dose should be individualized based on total serum calcium (albumin-corrected) and 24-hour urinary calcium excretion; maintenance dose is the minimum dose required to achieve serum calcium within the lower half of the normal range without the need for active forms of vitamin D and with calcium supplementation sufficient to meet the patient's daily requirements. -With each dose change, monitor clinical response and serum calcium; adjust active vitamin D and calcium supplementation as needed (see dosage adjustment section). -Due to potential risk of osteosarcoma, use should be reserved for those who cannot be well-controlled on calcium supplements and active forms of vitamin D alone. Use: An adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.

    Warnings

    In animal studies, parathyroid hormone caused bone cancer. However, it is not known whether these effects would occur in humans.

    While using Natpara, you may have high levels of calcium in your blood. Call your doctor if you have muscle weakness, lack of energy, nausea, vomiting, or constipation.

    After you stop using Natpara, you may have low calcium levels. Tell your doctor if you have numbness or tingling around your mouth or in your fingers and toes, muscle twitching in your face, cramps in your hands and feet, mood changes, or problems with thinking or memory.

    What other drugs will affect Natpara

    Tell your doctor about all your other medicines, especially:

  • alendronate (Fosamax);
  • digoxin; or
  • vitamin or mineral supplements that contain calcium or vitamin D.

    • This list is not complete. Other drugs may interact with parathyroid hormone, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords